companydata.dkONCONOX ApS: Financial statements 2013
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -190,816 compared with DKK -712,491 the year before. Equity amounted to DKK 49,664. The solvency ratio was 39.2%.
- Profit/Loss
- -190,816 kr.
- Equity
- 49,664 kr.
- Total Assets
- 126,627 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | -191 t. | 50 t. | - |
| 2012 | - | -705 t. | -712 t. | 240 t. | - |
Find more companies like ONCONOX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
ONCONOX ApS has published its annual report for 2012. Gross profit came to DKK -705,254, and the net result was DKK -712,491.
As of May 5, 2013, Mai-Britt Zocca has joined the board of directors of ONCONOX ApS.
As of May 5, 2013, Ferdinando Nicoletti has joined the board of directors of ONCONOX ApS.
As of May 5, 2013, Gianni Garotta has joined the board of directors of ONCONOX ApS.
As of May 5, 2013, Hans Thalsgård Schambye has left the board of directors of ONCONOX ApS.
As of May 5, 2013, Frank Knudsen has left the board of directors of ONCONOX ApS.
As of April 2, 2013, Frank Knudsen has joined the board of directors of ONCONOX ApS.
As of April 2, 2013, Ole Bitsch-Jensen has left the board of directors of ONCONOX ApS.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.